Annual report pursuant to Section 13 and 15(d)

CONDENSED STATEMENT OF OPERATIONS (UNAUDITED)

v3.22.0.1
CONDENSED STATEMENT OF OPERATIONS (UNAUDITED)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Income Statement [Abstract]      
Revenues $ 90,291 $ 68,801 $ 56,338
Cost of revenues 17,785 12,365 10,583
Gross profit 72,506 56,436 45,755
Operating expenses:      
Research and development 24,619 18,283 14,766
Sales and marketing 33,056 28,810 29,409
General and administrative 20,680 8,221 7,625
Total operating expenses 78,355 55,314 51,800
Operating (loss) profit (5,849) 1,122 (6,045)
Finance expenses, net 4,386 734 387
Total income (loss) before income taxes (10,235) 388 (6,432)
Taxes on income (1,237) (1,200) (902)
Net loss (11,472) (812) (7,334)
Accretion of preferred stock to redemption value (77,063) (7,297) (2,007)
Net loss attributable to common stockholders, basic (88,535) (8,109) (9,341)
Net loss attributable to common stockholders, diluted $ (88,535) $ (8,109) $ (9,341)
Denominator:      
Net loss per stock attributable to common stockholders – basic (in dollars per share) | $ / shares $ (3.31) $ (0.51) $ (0.59)
Net loss per stock attributable to common stockholders – diluted (in dollars per share) | $ / shares $ (3.31) $ (0.51) $ (0.59)
Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders, basic (in shares) | shares 26,745,020 16,028,560 15,886,958
Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders, diluted (in shares) | shares 26,745,020 16,028,560 15,886,958
Exchange ratio 1.337